Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediatorsSuelen da Silva Gomes Dias, Patrı́cia T. Bozza, Vinícius Cardoso Soares et al.|PLoS Pathogens|2020Cited by 321
SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytesAndré C. Ferreira, Thiago Moreno L. Souza, Mayara Mattos et al.|Cell Death Discovery|2021Cited by 279
Atazanavir, Alone or in Combination with Ritonavir, Inhibits SARS-CoV-2 Replication and Proinflammatory Cytokine ProductionNatalia Fintelman‐Rodrigues, Thiago Moreno L. Souza, Carolina Q. Sacramento et al.|Antimicrobial Agents and Chemotherapy|2020Cited by 142
Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivoCaroline S. de Freitas, Thiago Moreno L. Souza, Luiza M. Higa et al.|PLoS neglected tropical diseases|2019Cited by 124
Sofosbuvir protects Zika virus-infected mice from mortality, preventing short- and long-term sequelaeAndré C. Ferreira, Thiago Moreno L. Souza, Camila Zaverucha-do-Valle et al.|Scientific Reports|2017Cited by 115